NCT03320525View on ClinicalTrials.gov

Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN)

PHASE1TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

September 25, 2018

Study Completion Date

September 25, 2018

Conditions
Advanced Solid Tumors
Interventions
DIETARY_SUPPLEMENT

T-ChOS

T-ChOS 600 mg (two capsules, each 300 mg) daily in the morning 30 minutes before food.

Trial Locations (1)

2730

Herlev & Gentofte University Hospital, Denmark, Herlev

Sponsors

Collaborators (1)

GENIS
All Listed Sponsors
collaborator

GENIS

UNKNOWN

lead

Herlev Hospital

OTHER

NCT03320525 - Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN) | Biotech Hunter | Biotech Hunter